English

Other medication (tblMED)

26 forms  
Other medication
Description

Other medication

Alias
UMLS CUI-1
C0013227
UMLS CUI-2
C2347852
UMLS CUI-3
C0019682
Patient ID
Description

PATIENT

Data type

text

Alias
UMLS CUI [1]
C2348585
Code representing the treatment
Description

MED_ID

Data type

text

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0805701
Date of Initiation of Treatment
Description

MED_SD

Data type

date

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0808070
Date of stopping treatment
Description

MED_ED

Data type

date

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0806020
reason for stopping treatment
Description

MED_RS

Data type

integer

Alias
UMLS CUI [1]
C2133636
Back to the top of the page

Similar models

Other medication (tblMED)

26 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Other medication
C0013227 (UMLS CUI-1)
C2347852 (UMLS CUI-2)
C0019682 (UMLS CUI-3)
PATIENT
Item
Patient ID
text
C2348585 (UMLS CUI [1])
Item
Code representing the treatment
text
C0013227 (UMLS CUI [1,1])
C0805701 (UMLS CUI [1,2])
MED_ID
Code List
Code representing the treatment
CL Item
Insulin or derivatives hereof (A10A)
CL Item
Oral antidiabetic agents (A10B)
CL Item
Anabolic steroids/appetite stimulants (A14A)
CL Item
Anti-platelets (B01AC)
CL Item
Other anti-hypertensive agents [C02, C03, C04, C07, C08] (C-HYP)
CL Item
ACE inhibitors (C09)
CL Item
Lipid lowering agents (C10)
CL Item
Minocycline (MINOCIN) (J01AA08)
CL Item
Trimethoprim (MONOTRIM, NOPIL) (J01EA01)
CL Item
Sulfadiazine (J01EC02)
CL Item
Cotrimoxazole - Comb. of sulfonamides and trimethoprim (BACTRIM, EUSAPRIM, NOPIL) (J01EE)
CL Item
Sulfamethoxazole and trimethoprim (Bactrim) (J01EE01)
CL Item
Sulfametrole and trimethoprim - Cosoltrime (MADERAN) (J01EE03)
CL Item
Clarithromycine (KLACID) (J01FA09)
CL Item
Azithomycine (ZITHROMAX) (J01FA10)
CL Item
Clindamycine (DALACIN) (J01FF01)
CL Item
Amikacine (AMIKINE) (J01GB06)
CL Item
Ciprofloxacine (CIPROXINE, CILOXAN) (J01MA02)
CL Item
Levofloxacin (TAVANIC) (J01MA12)
CL Item
Moxifloxacin (J01MA14)
CL Item
Cosoltrime (MADERAN) (J01RA02)
CL Item
Amphotericin B (FUNGIZON) (J02AA01)
CL Item
Imidazoles (DAKTARIN, NIZORAL, PEVARYL …) (J02AB)
CL Item
Ketoconazole (J02AB02)
CL Item
Fluconazole (DIFLUCAN) (J02AC01)
CL Item
Itraconazole (SPORANOX) (J02AC02)
CL Item
Voriconazole (J02AC03)
CL Item
Posaconazole (J02AC04)
CL Item
Flucytosine (J02AX01)
CL Item
Rifampin (RIMATICIN) (J04AB02)
CL Item
Rifabutin (MYCOBUTIN) (J04AB04)
CL Item
Isoniazide (RIMIFON) (J04AC01)
CL Item
Pyrazinamide (PYRAZINAMID) (J04AK01)
CL Item
Ethambutol (EMB, MYAMBUTOL) (J04AK02)
CL Item
RIFATER (J04AM05)
CL Item
Clofazimine (LAMPREN) (J04BA01)
CL Item
Dapsone (J04BA02)
CL Item
Aciclovir (ZIVORAX) (J05AB01)
CL Item
Ribavirin (J05AB04)
CL Item
Ganciclovir (CYMEVENE) (J05AB06)
CL Item
Famciclovir (J05AB09)
CL Item
Valaciclovir (VALTEX) (J05AB11)
CL Item
Cidofovir (VISTIDE) (J05AB12)
CL Item
Valganciclovir (J05AB15)
CL Item
Foscarnet (FOSCAVIR) (J05AD01)
CL Item
Boceprevir (VICTRELIS) (J05AE12)
CL Item
Telaprevir (INCIVEK, INCIVO) (J05AE11)
CL Item
Cyclophosphamide (ENDOXAN) (L01AA01)
CL Item
CCNU (LOMUSTINE) (L01AD02)
CL Item
Dacabazine (DTIC - Dome) (L01AX04)
CL Item
Methotrexate (L01BA01)
CL Item
Vinblastin (VELBE) (L01CA01)
CL Item
Oncovin (VINCRISTINE) (L01CA02)
CL Item
Etoposide (VEPESIDE, EXITOP 100) (L01CB01)
CL Item
Doxorubicine, Adriamycine (DOXIL, CAELYX, ADRIBLASTIN) (L01DB01)
CL Item
Bleomycine (L01DC01)
CL Item
Procarbazine (NATULAN) (L01XB01)
CL Item
G-CSF/Filgastrim (NEUPOGEN) (L03AA02)
CL Item
Interferons (L03AB)
CL Item
Peginterferon alfa-2a/alfa-2b (PEGINTRON, PEGASYS) (L03AB-AL2)
CL Item
Peginterferon alfa-2b (PEGINTRON) (L03AB10)
CL Item
Peginterferon alfa-2a (PEGASYS) (L03AB11)
CL Item
Interleukin 2 (PROLEUKIN) (L03AC-IL2)
CL Item
Atovaquone (WELLVONE, MEPRONE) (P01AX06)
CL Item
Primaquine (P01BA03)
CL Item
Pyrimethamine (DARAPRIM) (P01BD01)
CL Item
Pyrimethamine/Sulfadoxine (FANSIDAR) (P01BD51)
CL Item
Pentamidine aerosol (PENTACARNET) (P01CX01)
CL Item
Folinate of calcium (LEUCOVORINE) (V03AF03)
CL Item
Antibiotics (J01)
CL Item
Corticosteroids (H02)
CL Item
Tocolysis (G02CA)
MED_SD
Item
Date of Initiation of Treatment
date
C0013227 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
MED_ED
Item
Date of stopping treatment
date
C0013227 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Item
reason for stopping treatment
integer
C2133636 (UMLS CUI [1])
MED_RS
Code List
reason for stopping treatment
CL Item
Treatment failure (i.e. virological, immunological, and/or clinical failure (1)
CL Item
Virological failure (1.1)
CL Item
Partial virological failure (1.2)
CL Item
Immunological failure - CD4 drop (1.3)
CL Item
Clinical progression (1.4)
CL Item
Abnormal fat redistribution (2)
CL Item
Concern of cardiovascular disease (3)
CL Item
Dyslipidaemia (3.1)
CL Item
Cardiovascular disease (3.2)
CL Item
Hypersensitivity reaction (4)
CL Item
Toxicity, predominantly from abdomen/G-I tract (5)
CL Item
Toxicity - GI tract (5.1)
CL Item
Toxicity - Liver (5.2)
CL Item
Toxicity - Pancreas (5.3)
CL Item
Toxicity, predominantly from nervous system (6)
CL Item
Toxicity - peripheral neuropathy (6.1)
CL Item
Toxicity - neuropsychiatric (6.2)
CL Item
Toxicity - headache (6.3)
CL Item
Toxicity, predominantly from kidneys (7)
CL Item
Toxicity, predominantly from endocrine system (8)
CL Item
Diabetes (8.1)
CL Item
Haematological toxicity (anemia etc.) (9)
CL Item
Hyperlactataemie/lactic acidosis (10)
CL Item
Death (88)
CL Item
Side effects - any of the above but unspecified (90)
CL Item
Comorbidity (90.1)
CL Item
Toxicity, not mentioned above (91)
CL Item
Toxicity, unspecified (91.1)
CL Item
Availability of more effective treatment (not specifically failure or side effect related) (92)
CL Item
Simplified treatment available (92.1)
CL Item
Treatment too complex (92.2)
CL Item
Drug interaction (92.3)
CL Item
Drug interaction - commencing TB/BCG treatment (92.31)
CL Item
Drug interaction - ended TB/BCG treatment (92.32)
CL Item
Change in eligibility criteria (e.g. child old enough for tablets; refrigerator no longer available) (92.33)
CL Item
Protocol change (92.4)
CL Item
Change in treatment not due to side-effects, failure, poor adherence or contra-indication (92.9)
CL Item
Structured Treatment Interruption (STI) (93)
CL Item
Structured Treatment Interruption (STI) - at high CD4 (93.1)
CL Item
Patient's wish/decision, not specified above (94)
CL Item
Non-compliance (94.1)
CL Item
Defaulter (94.2)
CL Item
Physician's decision, not specified above (95)
CL Item
Pregnancy (96)
CL Item
Pregnancy intended (96.1)
CL Item
Pregnancy ended (96.2)
CL Item
Study treatment (97)
CL Item
Study treatment commenced (97.1)
CL Item
Study treatment completed (97.2)
CL Item
Drug not available (97.6)
CL Item
Other causes, not specified above (98)
CL Item
Unknown (99)
Back to the top of the page